These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6169296)

  • 1. [Combination of pentoxifylline with other rheologic agents in the treatment of ischemic pain at rest].
    Aced S; Cairols MA; Marco-Luque MA; Capdevila JM
    Angiologia; 1981; 33(4):203-7. PubMed ID: 6169296
    [No Abstract]   [Full Text] [Related]  

  • 2. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
    Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous pentoxifylline in the treatment of rest pain: a preliminary report.
    McCollum PT; Kent P; O'Driscoll K; Carey D; Stanley ST; Weil von der Ahe CA; Moore DJ; Shanik DG
    Ann Vasc Surg; 1989 Jul; 3(3):220-3. PubMed ID: 2775635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative evaluation of the efficacy of various methods in the treatment of diabetic retinopathies].
    Gol'tseva SV
    Oftalmol Zh; 1983; 38(1):36-8. PubMed ID: 6866402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rheologic effect of naftidrofuryl and pentoxifylline].
    Radtke H; Kiesewetter H; Roggenkamp HG; Jung F
    Med Welt; 1983 Jul; 34(29-30):833-6. PubMed ID: 6621333
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dipyridamole plus pentoxifylline in patients with diffuse cerebrovascular insufficiency.
    Yayá R; Aznar J; Vayá A; Villa P; Santos T; Vallés J; Martinez-Sales V
    Thromb Haemost; 1985 Dec; 54(4):896. PubMed ID: 3911484
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

  • 9. [Parenteral pentoxifylline treatment of ischemic cerebrovascular accident. Preliminary results].
    Schneider R; Kiesewetter H
    Dtsch Med Wochenschr; 1982 Nov; 107(44):1674-7. PubMed ID: 7140544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheological effects of pharmacological treatment of inner ear disorders.
    Hörmann K
    Scand Audiol Suppl; 1986; 26():47-8. PubMed ID: 2437643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
    Turowski A; Schmidt HH; Sternitzky R
    Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
    Ott E; Lechner H
    Ric Clin Lab; 1981; 11 Suppl 1():253-6. PubMed ID: 7188113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis].
    Vogralik VG; Vogralik MV; Runov GP; Runova AA; Kostrov AI
    Klin Med (Mosk); 1982 Oct; 60(10):90-4. PubMed ID: 7176484
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of papaverine and trental on hemostasis and rheologic properties of blood in acute arterial obstruction].
    Zatevakhin II; Koshkin VM; Shestakov VA; Il'in SG; Adil'khanov SG
    Probl Gematol Pereliv Krovi; 1979 Dec; 24(12):40-3. PubMed ID: 523450
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
    Strano A; Davì G; Novo S; Avellone G; Pinto A
    Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences in therapy of acute labyrinthine deafness with low-molecular dextran, pentoxifyllin and nicotinic acid (author's transl)].
    Wissen I; Aziz MY
    Laryngol Rhinol Otol (Stuttg); 1981 Jul; 60(7):361-3. PubMed ID: 6178919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Pentoxifylline on flap survival.
    Takayanagi S; Ogawa Y
    Plast Reconstr Surg; 1980 Jun; 65(6):763-7. PubMed ID: 7384277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of vascular diseases of the extremities using pentoxifylline].
    Di Perri T
    Ric Clin Lab; 1988; 18 Suppl 2():49-56. PubMed ID: 3073515
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary vascular reactivity and hemorheology in patients with chronic cor pulmonale: responses to pentoxifylline at rest and during exercise.
    Sturani C; Palareti G; Poggi M; Schiavina M; Torricelli P; Papiris S; Coccheri S; Gunella G
    Ric Clin Lab; 1986; 16(4):569-78. PubMed ID: 3576055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
    Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
    Dtsch Med Wochenschr; 1987 May; 112(22):873-8. PubMed ID: 3556133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.